Loading data
RSKDNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 344.64 m USD | 327.52 m USD | 297.61 m USD | 261.25 m USD | 229.14 m USD |
| Cost of revenue | 166.57 m USD | 156.58 m USD | 145.09 m USD | 126.15 m USD | 106.17 m USD |
| Gross profit | 178.07 m USD | 170.94 m USD | 152.52 m USD | 135.1 m USD | 122.97 m USD |
| Research and development expense | 69.41 m USD | 68.07 m USD | 71.58 m USD | 72.01 m USD | 55.3 m USD |
| Operating profit | -34.04 m USD | -47.85 m USD | -76.85 m USD | -109.35 m USD | -55.94 m USD |
| Profit before tax | -21.21 m USD | -28.5 m USD | -53.24 m USD | -98.66 m USD | -177.87 m USD |
| Income tax expense | 6.36 m USD | 6.42 m USD | 5.8 m USD | 6.04 m USD | 1.56 m USD |
| Net income (reported basis) | -27.57 m USD | -34.92 m USD | -59.04 m USD | -104.71 m USD | -179.43 m USD |
| Basic earnings per share | — | — | — | 0.62 USD/share | — |
| Diluted earnings per share | — | — | — | 0.62 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.